Vital KSK Holdings, Inc. (TYO:3151)
Japan · Delayed Price · Currency is JPY 1,526.00
-17.00 (-1.10%)
Jun 3, 2026, 1:55 PM JST
Vital KSK Holdings Market Cap
Vital KSK Holdings has a market cap or net worth of 74.65 billion as of June 2, 2026. Its market cap has increased by 15.65% in one year.
Market Cap
74.65B
Enterprise Value
59.95B
Revenue
610.50B
Ranking
n/a
PE Ratio
10.13
Stock Price
1,526.00
Market Cap Chart
Since August 5, 2009, Vital KSK Holdings's market cap has increased from 31.59B to 74.65B, an increase of 136.28%. That is a compound annual growth rate of 5.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 74.65B | 12.63% |
| Dec 30, 2025 | 66.28B | 9.74% |
| Dec 30, 2024 | 60.39B | 15.24% |
| Dec 29, 2023 | 52.41B | 19.05% |
| Dec 30, 2022 | 44.02B | 1.53% |
| Dec 30, 2021 | 43.35B | -3.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.54T |
| HOYA Corporation | 8.81T |
| Takeda Pharmaceutical Company | 7.66T |
| Otsuka Holdings | 5.96T |
| ASKA Pharmaceutical Holdings | 78.40B |
| Cawachi | 73.70B |
| Oncolys BioPharma | 73.59B |
| KYORIN Pharmaceutical | 68.82B |